Page last updated: 2024-10-25

clotrimazole and Meningitis, Cryptococcal

clotrimazole has been researched along with Meningitis, Cryptococcal in 1 studies

Meningitis, Cryptococcal: Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2)

Research Excerpts

ExcerptRelevanceReference
"The use of preventive treatment for fungal infections is cautioned due to the possibility of resistance to treatment."1.29Fungal infection overview. ( , 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Other Studies

1 other study available for clotrimazole and Meningitis, Cryptococcal

ArticleYear
Fungal infection overview.
    Treatment review, 1995, Issue:no 18

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Candidiasis

1995